logo-loader

IXICO lands multiple contracts to battle Alzheimer's disease

Published: 08:21 04 Nov 2020 GMT

IXICO PLC's (LON:IXI) Lammert Albers talks to Proactive London about landing three new contracts, with three different customers in the area of Alzheimer's disease.

Albers talks through each of the projects, which includes a phase I study, an expansion deal for a phase II clinical assessment, and it will deploy its expertise on an open-label extension phase III trial.

Albers also highlights the importance of the CTAD and the Aducanumab advisory committee meeting this Friday, which will take place virtually this year.

Oriole Resources outlines 2023 achievements and future exploration plans

Oriole Resources PLC (AIM:ORR) CEO Tim Livesey and chief financial officer Bob Smeeton join Proactive's Stephen Gunnion with details of the company's 2023 financial and operational performance. Livesey highlighted successful exploration programs in Cameroon, at the Bibemi and Mbe projects,...

1 hour, 46 minutes ago